Researchers report promising results for the viability of a portable, handheld device using a specialized light technique that may enhance the differential diagnosis of non-melanoma skin cancers, inflamed scar tissue and normal skin in vivo.
Globalepolicy.org is a free to access global medical news service for the consumer, professional and researcher.
Background: A treatment algorithm and screening examination have been developed to guide patient management and prospectively determine potential for highly active individuals to succeed with nonoperative care after anterior cruciate ligament rupture.
Objective: To prospectively characterize and classify the entire population of highly active individuals over a 10-year period and provide final outcomes for individuals who elected nonoperative care.
Methods: Inclusion criteria included presentation within 7 months of the index injury and an International Knee Documentation Committee level I or II activity level before injury. Concomitant injury, unresolved impairments, and a screening examination were used as criteria to guide management and classify individuals as noncopers (poor potential) or potential copers (good potential) for nonoperative care.
Results: A total of 832 highly active patients with subacute anterior cruciate ligament tears were seen over the 10-year period; 315 had concomitant injuries, 87 had unresolved impairments, and 85 did not participate in the classification algorithm. The remaining 345 patients (216 men, 129 women) participated in the screening examination a mean of 6 weeks after the index injury. There were 199 subjects classified as noncopers and 146 as potential copers. Sixty-three of 88 potential copers successfully returned to preinjury activities without surgery, with 25 of these patients not undergoing anterior cruciate ligament reconstruction at the time of follow-up.
Conclusion: The classification algorithm is an effective tool for prospectively identifying individuals early after anterior cruciate ligament injury who want to pursue nonoperative care or must delay surgical intervention and have good potential to do so.
NAVIGATION
|
17
Nov |
Skin Cancer - Study Shows Novel Light Device Detects Cancerous Lesions From Normal TissueCategory: Dermatology | Leave a Comment |
Researchers report promising results for the viability of a portable, handheld device using a specialized light technique that may enhance the differential diagnosis of non-melanoma skin cancers, inflamed scar tissue and normal skin in vivo.
|
8
Oct |
Reliant Technologies Announces FDA 510(K) Clearance Of New Handpieces For Skin Resurfacing And Surgical ApplicationsCategory: Dermatology | Leave a Comment |
Reliant Technologies, Inc., the pioneer of fractional resurfacing and market leader of aesthetic laser skin treatments, announced that it has received FDA 510(k) clearance for three new Fraxel re:pair laser handpieces. These handpieces expand the capabilities of the Fraxel re:pair laser system, providing physicians with a complete skin resurfacing and surgical treatment option.
|
1
Oct |
Stratatech Successfully Completes Clinical Trial Of StrataGraft® Skin Substitute - Trial’s Primary Clinical Endpoint AchievedCategory: Dermatology | Leave a Comment |
Stratatech Corp. , a regenerative medicine company focused on the development and commercialization of cell-based, tissue-engineered skin substitute products, today announced that it has successfully completed the multi-center, 15-patient clinical trial of its StrataGraft®
|
17
Sep |
What Is The Potential Of The Wound Care Market In Eastern Europe?Category: Dermatology | Leave a Comment |
The Healthcare group at Frost & Sullivan (http://www.healthcare.frost.com/) is pleased to announce that it will be hosting an interactive analyst briefing on the Wound Care Market in Eastern Europe on 23 September 2008 at 3pm BST (2pm GMT). The accession of a number of Eastern European countries to the EU has helped to position the region as a growing market for the medical device industry.
|
19
Aug |
Funding For Clinical Trials For New Probe To Detect Skin CancerCategory: Dermatology | Leave a Comment |
Assistant Professor James Tunnell has been awarded a Phase II Early Career Award from the Wallace H. Coulter Foundation to continue the development and testing of a device that uses light to detect skin cancer without the need for an invasive biopsy procedure. The $260,000 grant will support Tunnell’s work for the next two years to refine the device called a “clinical spectrometer” and to conduct additional clinical trials.